United Therapeutics
UTHR
$238.95
Share price
-0.79%
Change (1 day)
36.82%
Change (1 year)
Market capitalization of United Therapeutics (UTHR)
Market cap: $10.82 Billion
As of June 2022 United Therapeutics has a market cap of $10.82 Billion. This makes United Therapeutics the world's 1318th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of United Therapeutics from 2001 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $9.93 B | 2.12% |
| 2021 | $9.73 B | 44.26% |
| 2020 | $6.74 B | 74.52% |
| 2019 | $3.86 B | -18.57% |
| 2018 | $4.74 B | -25.75% |
| 2017 | $6.39 B | 5.09% |
| 2016 | $6.08 B | -15.11% |
| 2015 | $7.16 B | 17.49% |
| 2014 | $6.09 B | 7.06% |
| 2013 | $5.69 B | 112.62% |
| 2012 | $2.67 B | -2.77% |
| 2011 | $2.75 B | -24.25% |
| 2010 | $3.63 B | 27.46% |
| 2009 | $2.85 B | 96.48% |
| 2008 | $1.45 B | -33.12% |
| 2007 | $2.17 B | 86.06% |
| 2006 | $1.16 B | -27.56% |
| 2005 | $1.61 B | 59.16% |
| 2004 | $1.01 B | 107.06% |
| 2003 | $0.48 B | 39.97% |
| 2002 | $0.34 B | 65.96% |
| 2001 | $0.21 B |
End of Day market cap according to different sources
On Jun 23rd, 2022 the market cap of United Therapeutics was reported to be:
$10.91 Billion
$10.91 Billion
$10.84 Billion
$10.89 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $289.46 B | 2,574.22% | 🇺🇸 USA |
 Eli Lilly LLY | $309.39 B | 2,758.30% | 🇺🇸 USA |
 Baxter BAX | $33.62 B | 210.65% | 🇺🇸 USA |
 Gilead Sciences GILD | $79.78 B | 637.09% | 🇺🇸 USA |
 Cardinal Health CAH | $14.83 B | 37.04% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $111.06 B | 926.03% | 🇬🇧 UK |
 Cytokinetics
CYTK | $4.04 B | -62.61% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.82 B | -18.48% | 🇮🇱 Israel |